大学六级-1249及答案解析.doc
《大学六级-1249及答案解析.doc》由会员分享,可在线阅读,更多相关《大学六级-1249及答案解析.doc(36页珍藏版)》请在麦多课文档分享上搜索。
1、大学六级-1249 及答案解析(总分:713.00,做题时间:90 分钟)一、Part Writing(总题数:1,分数:106.00)1.电视节目中广告很多2广告的利与弊3我的观点On Television Advertisement_(分数:106.00)_二、Part Reading Compr(总题数:1,分数:70.00)HIV Vaccine Feat Leaves More Questions Than AnswersOnly hours after HIV vaccine researchers announced the achievement of a milestone
2、that has eluded them for a quarter of a century, they began plotting their next stepsand coming back to reality. Their ultimate goal, halting the spread of AIDS, remains far in the future. A Thai and American team had announced early Thursday in Bangkok that they had found a combination of vaccines
3、that provided modest protection against infection with HIV, offering the first proof of principle that the deadly disease could be tamed by teaching the immune system to recognize the virus and defeat it. Scientists around the world hailed the achievement.But by Thursday afternoon, the initial wave
4、of joy had given way to the recognition that many questions will have to be answered before researchers can produce a vaccine that will reliably shield people from HIV. For starters, it could take years to figure out the biological mechanisms that produced the apparent 31 reduction in infections amo
5、ng those given the vaccine treatment.Researchers have never before observed antibodies (抗体) or other molecules in the blood that could block an infection of HIV, the virus that causes AIDS. Now they will try to figure out whether this combination of vaccines stimulated new molecules, or provoked an
6、unusual blend of ones previously observed. Experts predicted that it would require 2 to 3 years of research to better understand how the vaccine worked, and an additional 5 to 10 years to produce a vaccine that was ready to test in people. Some researchers even wondered whether the apparent reductio
7、n in infections was simply a statistical mistake resulting from the small number of HIV cases observed in the trial.The abundance of unanswered questions hasnt sapped the enthusiasm of many HIV researchers. After 26 years of seemingly futile research on vaccines, they have finally made some progress
8、 on demonstrating the feasibility of an HIV vaccine, said Dr. Anthony Fauci, director of the National Institute of Allergy and Infectious Diseases, which largely funded the $120-million study. “This is the first positive signalmodest though it may bethat we have ever got with any vaccine that we hav
9、e ever tested in humans,“ Fauci said. But “is it a vaccine that is ready for prime time? No.“The Thai trial, which began in 2003, had been laughed at by many critics as a waste of time and money because its two vaccines had produced no benefit in individual trials. But a few researchers speculated t
10、hat using them togetherwith one vaccine priming (开始修复) the immune system and the second boosting that responsewould be more effective. The primer in this combination is Alvac, made by Sanofi Pasteur, which uses a harmless virus to carry three synthetic HIV genes into the body. :The boost comes from
11、Aidsvax, originally made by VaxGen Inc. and now owned by the nonprofit group Global Solutions for Infectious Diseases. It contains a genetically engineered version of a protein from the HIV surface.The study, led by Dr. Supachai Rerks-Ngarm of the Thai Ministry of Public Healths Department of Diseas
12、e Control, involved more than 16,000 volunteers in Thailand, all from the general population rather than from a pool of high-risk homosexuals and drug users used in past studies. Half received four priming doses of Alvac and two boost doses of Aidsvax over a six-month period; the other half received
13、 placebo (无效对照药) shots. After three years of follow-up, new HIV infections were observed in 74 of the 8,198 people who received the placebo, but in only 51 of the 8,197 given the vaccine, a statistically significant 31% reduction.To the researchers disappointment, however, the vaccine did not reduce
14、 levels of HIV activity in those who became infected after being vaccinated. The trial was carried out in Thailand because the initial research was conducted there and the vaccine was based on the version of HIV that circulates in that country. Full details of the study will be released next month a
15、t a conference in Paris, and researchers are eagerly awaiting them.Dr. Salim S. Abdool Karim, an epidemiologist at Columbia University in New York and director of the Centre for the AIDS Programme of Research in South Africa in Durban, said he was particularly eager to know whether people who got va
16、ccinated and stayed healthy had a bigger response from the white blood cells known as cellular T lymphocytes(淋巴球). “A whole range of vaccines were developed on the hypothesis(遐想) that they generated sufficient cellular T lymphocyte responses to prevent infection,“ he said. “Weve never been able to t
17、est that hypothesis because no vaccine has worked until now.“And if it is not the lymphocytes, then “what kind of compounds were the cells making when you inoculate them with the vaccine?“ asked Dr. Spyros Kalams, an HIV immunology researcher at Vanderbilt University in Nashville and director of the
18、 HIV Vaccine Trials Program there. “Was it a compound that can kill infected cells? Does it make proteins that stop the virus from replicating?“ Researchers now will begin the painstaking work of comparing the blood of those who were vaccinated and resisted infection and those who did not. Then they
19、 will look for molecules that are more abundant in the healthy people, Fauci said.Once researchers identify these so-called correlates of immunity, they can begin to look for ways to prompt the body to make themthe key to producing an effective vaccine. The Thai results are “an opening of a door to
20、answer some very important questions,“ he said. But several scientists cautioned that there was no guarantee the Thai blood samples would reveal the biological secrets of HIV immunity. Surely some of the people who resisted HIV infection were protected by the vaccine, but not all, said Dr. Otto Yang
21、, an immunologist at UCLAs David Geffen School of Medicine.Yang also expressed doubt that a combination of vaccines made the difference in those who benefited. He and others noted that this was the first large study to focus on a low-risk population. Perhaps transmitting the virus through heterosexu
22、al sex instead of directly into the bloodstream on an needle gives the immune system a better chance of fighting off infection. Although it is also unclear whether these particular vaccines could be used elsewhere in the world, scientists said that if they could figure out what made this combination
23、 work, they could localize the approach to other regions. The dominant HIV strains vary from region to region.At least 33 million people worldwide are infected with HIV and 25 million have died, the World Health Organization said. An estimated 7,500 are infected each day, emphasizing the need for a
- 1.请仔细阅读文档,确保文档完整性,对于不预览、不比对内容而直接下载带来的问题本站不予受理。
- 2.下载的文档,不会出现我们的网址水印。
- 3、该文档所得收入(下载+内容+预览)归上传者、原创作者;如果您是本文档原作者,请点此认领!既往收益都归您。
下载文档到电脑,查找使用更方便
2000 积分 0人已下载
下载 | 加入VIP,交流精品资源 |
- 配套讲稿:
如PPT文件的首页显示word图标,表示该PPT已包含配套word讲稿。双击word图标可打开word文档。
- 特殊限制:
部分文档作品中含有的国旗、国徽等图片,仅作为作品整体效果示例展示,禁止商用。设计者仅对作品中独创性部分享有著作权。
- 关 键 词:
- 大学 1249 答案 解析 DOC
